Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
1 clinical trials · Condition
◉ Watch Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
| Record | Firm | Date |
|---|---|---|
| Clinical Efficacy and Safety of CD47 Monoclonal Antibody Combined With Azacitidine in the Treatment of Recurrent AML After Transplantation (NCT05266274) | The First Affiliated Hospital of Soochow University | 2021-12-14 |
Track Patients With Recurrent Acute Myelogenous Leukemia After Transplantation automatically
Every clearance here is in the API, with alerts when new ones post.